|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Change in fair value of convertible debt | |
| Non-cash amortization of other debt discount | |
| Provision for excess and obsolete inventory | |
| Stock-based compensation expense | |
| Depreciation | |
| Bad debt expense | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | |
| Inventory | |
| Prepaid expenses and other assets | |
| Accounts payable | |
| Accrued expenses | |
| Deferred revenue | |
| Accrued interest | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Capital expenditures | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from convertible debt | |
| Repayments of convertible debt | |
| Proceeds from other debt issuances | |
| Fees paid for debt issuance | |
| Repayment of other debt issuances | |
| Proceeds from issuance of common stock from equity line-of-credit | |
| Proceeds from exercise of common stock options | |
| Net cash provided by financing activities | |
| Effects of exchange rate changes on cash and cash equivalents | |
| Net (decrease) increase in cash, cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash, beginning of period | |
| Cash, cash equivalents and restricted cash, end of period | |
| Supplemental disclosure of cash flow information: | |
| Cash paid for interest | |
| Cash paid for income taxes | |
| Non-cash investing and financing activities: | |
| Conversion of convertible debt principal and interest payments into common stock |
Loading...
